BIO VEINO
Food supplement declared in France, declaration No 2017-3-150
BIO VEINO is a food supplement declared in France. Status: retiré du marché le 30 January 2025. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- LABORATOIRES SCIENCE ET ÉQUILIBRE
- Status
- Retiré du marché le 30 January 2025
- Form
- Comprimé
- Daily dose
- 4 comprimés par jour.
- Directions for use
- 4 comprimés par jour (2 le matin, 2 le soir) à avaler avec un grand verre d'eau.
- Not recommended for (according to the manufacturer)
- Sous anticoagulants
- Objectives stated by the manufacturer (these are not authorised claims)
- Circulation sanguine et lymphatique
Declaration 279402, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retiré du marché le 30 January 2025, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Hibiscus sabdariffa L. | Fleur | Extrait sec aqueux | 750 mg |
| Cupressus sempervirens L. | Cône femelle | Poudre (de plantes séchées ou broyées) | 200 mg |
| Olea europaea L. | Feuille | Poudre (de plantes séchées ou broyées) | 200 mg |
| Aesculus hippocastanum L. | Graine | Extrait sec aqueux | 187.5 mg |
| Chrysanthellum indicum subsp. afroamericanum B.L.Turner | Parties aériennes | Poudre (de plantes séchées ou broyées) | 150 mg |
| Hieracium pilosella L. | Parties aériennes | Poudre (de plantes séchées ou broyées) | 150 mg |
| Crataegus laevigata (Poir.) DC. | Sommités fleuries | Extrait sec aqueux | 100 mg |
Additives
E504
Other ingredients
maltodextrine, sirop de riz, huile de tournesol
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Déconseillé aux personnes sous traitement anticoagulant.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.